 | Up a level |
Journal Article
Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Fruehwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I, Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F. H., Theissen, J., Volland, R., Hero, B. and Simon, T. (2020). Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann. Oncol., 31 (3). S. 422 - 430. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Klein, H., Volland, R., Ehren, R., Habbig, S., Liebau, M. C., Nuesken, K. D., Taylan, C. and Weber, L. T. (2017). STEROID WITHDRAWAL WITHIN THE FIRST YEAR AFTER PEDIATRIC KIDNEY TRANSPLANTATION - ELEVATED RISK FOR THE DEVELOPMENT OF DE NOVO DONOR-SPECIFIC ANTIBODIES (DNDSA) AND ACUTE REJECTION EPISODES (ARE)? Pediatr. Transplant., 21. S. 21 - 22. HOBOKEN: WILEY. ISSN 1399-3046
Matthies, J., Huenseler, C., Ehren, R., Volland, R., Koerber, F., Hoppe, B., Weber, L. T. and Habbig, S. (2016). Extrarenal Manifestations in Shigatoxin-associated Haemolytic Uremic Syndrome. Klinische Padiatr., 228 (4). S. 181 - 189. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824